These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8780847)

  • 1. Successful zidovudine (AZT) treatment in a case of human immunodeficiency virus (HIV)-1-associated dementia complex.
    Sobanski T; Assion HJ; Scholl HP; Höflich G; Laux G
    Biol Psychiatry; 1996 Jun; 39(12):1065-6. PubMed ID: 8780847
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
    Simpson DM
    Clin Infect Dis; 1999 Jul; 29(1):19-34. PubMed ID: 10433561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism with HIV infection.
    Mirsattari SM; Power C; Nath A
    Mov Disord; 1998 Jul; 13(4):684-9. PubMed ID: 9686775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits.
    Galgani S; Balestra P; Narciso P; Tozzi V; Sette P; Pau F; Visco G
    AIDS; 1997 Oct; 11(12):1520-1. PubMed ID: 9342076
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and biologic features of the AIDS dementia complex.
    Navia BA
    Neuroimaging Clin N Am; 1997 Aug; 7(3):581-92. PubMed ID: 9376969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of HIV encephalopathy with dementia which showed significant improvement after the combination antiretroviral therapy].
    Mizoi Y; Takagi M; Hoshino H; Matsuoka S; Adachi T
    Rinsho Shinkeigaku; 2000 Feb; 40(2):178-80. PubMed ID: 10835942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system.
    Delforge ML; Farber CM; De Leener F; Caroyer JM; Liesnard C; Van Vooren JP
    Clin Infect Dis; 1999 Apr; 28(4):931. PubMed ID: 10825078
    [No Abstract]   [Full Text] [Related]  

  • 8. Information processing and antiretroviral therapy in HIV-1 infection.
    Martin EM; Pitrak DL; Pursell KJ; Andersen BR; Mullane KM; Novak RM
    J Int Neuropsychol Soc; 1998 Jul; 4(4):329-35. PubMed ID: 9656606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain].
    von Giesen HJ; Köller H; Arendt G
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():46-50. PubMed ID: 12043074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal comparison of HIV-1 RNA burden in plasma and cerebrospinal fluid in two patients starting triple combination antiretroviral therapy.
    Iftimovici E; Rabian C; Burgard M; Peytavin G; Rouzioux C; Viard JP
    AIDS; 1998 Mar; 12(5):535-7. PubMed ID: 9543456
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk of the development of dementia after interruption of zidovudine treatment].
    Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM
    Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
    Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
    J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-associated CNS disease in infants and children.
    Belman AL
    Res Publ Assoc Res Nerv Ment Dis; 1994; 72():289-310. PubMed ID: 8115719
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
    Wool M
    Posit Dir News; 1998 Jan; 10(1):18-24. PubMed ID: 11365052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV seropositive patients no longer fit to drive? Silent encephalitis--early therapy with AZT?].
    Näthke HE
    Fortschr Med; 1989 Oct; 107(29):32. PubMed ID: 2807123
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the AIDS dementia complex in adults.
    Sidtis JJ
    Res Publ Assoc Res Nerv Ment Dis; 1994; 72():273-87. PubMed ID: 8115718
    [No Abstract]   [Full Text] [Related]  

  • 17. Zidovudine treatment is not associated with HTLV-1 reverse transcriptase gene mutations in HTLV-I/HIV-1 co-infected patients.
    Gasmi M; Fillon S; Leriche K; Neisson-Vernant C; Desgranges C
    Antivir Ther; 1997 Apr; 2(2):91-7. PubMed ID: 11322280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
    Jeeninga RE; Keulen W; Boucher C; Sanders RW; Berkhout B
    Virology; 2001 May; 283(2):294-305. PubMed ID: 11336554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decrease in notifications of AIDS dementia complex in 1989-1990 in Italy: possible role of the early treatment with zidovudine].
    Chiesi A; Agresti MG; Dally LG; Zaccarelli M; Tomino C; Floridia M; Vella S
    Medicina (Firenze); 1990; 10(4):415-6. PubMed ID: 2099987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of neuropsychiatric parameters in HIV positive subjects treated with zidovudine.
    Azzini M; Nanni S; Astori MR; Brunetto A; Massobrio L
    Acta Neurol (Napoli); 1990 Feb; 12(1):36-9. PubMed ID: 2336993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.